Jennifer Cormier

Jennifer serves as the Senior Vice President of Clinical Operations at PepGen. With over 15 years of pharmaceutical and medical device experience, Jennifer has lead development stage programs from Phase 1 (first in human) through post marketing approval studies across a range of therapeutic areas including rare genetic diseases, women’s health, Parkinson’s, diabetes/obesity, and major depressive disorder. Prior to joining PepGen, Jennifer served as Vice President of Clinical Operations at Relmada Therapeutics where she was responsible for oversight and execution of the late phase clinical program. Prior to Relmada, she served as Vice President of Clinical Operations at Sojournix where she was responsible for the strategy, oversight, and execution of first in human/early phase clinical program. Prior to Sojournix, Jennifer held various positions of increasing responsibilities in clinical operations, project management and Medical Affairs, leading global clinical programs and registry studies at Acorda Therapeutics, GI Dynamics and Shire. She earned her Bachelor of Science degree in Biology from University of Massachusetts Boston.